← Eichor
Study identifier: NCT07388953 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia After Minimally Invasive Left-Sided Colorectal Resection (BAPTAP)

Condition: Colorectal Cancer · Colorectal Surgery · Anesthesia  ·  Sponsor: Faculdade de Ciências Médicas de Minas Gerais

PhaseNA
Planned participants140
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Effective postoperative pain management is essential for enhanced recovery after laparoscopic colorectal surgery. This randomized, controlled, double-blind trial will compare conventional postoperative analgesia (intravenous medications plus surgical wound infiltration) with a locoregional strategy combining a peripheral autonomic block (inferior mesenteric and superior hypogastric plexuses) and a transversus abdominis plane (TAP) block. We hypothesize that the combined strategy (BAPTAP) reduces pain intensity and opioid consumption in the first 48 hours after Left-Sided Colorectal Resection.

This description comes directly from the study's public registry record.

Talk to the study team

MATHEUS MMMDE MEYER, MD  ·  5531988044987  ·  matheusww@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Santa Casa de Misericórdia de Belo HorizonteBelo Horizonte, Minas Gerais, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07388953